基本转录因子3像4通过调节瘤细胞功能和质瘤中的免疫微环境来增强恶性表型
Bing Lu1, Tianyi Lu2, Jiawen Shi1
1Department of Clinical Biobank and Institute of Oncology, Affiliated Hospital of Nantong University, Jiangsu, China.
The American journal of pathology
|February 6, 2024
概括
基本转录因子3像4 (BTF3L4) 在质瘤中升高,与预后不佳相关,并影响瘤细胞行为. 它与免疫细胞的关联表明,它有可能成为质瘤免疫治疗的目标.
科学领域:
- 神经瘤学神经瘤学
- 癌症免疫学 癌症免疫学
- 分子生物学分子生物学
背景情况:
- 质瘤免疫疗法反应受到瘤微环境的限制.
- 基性转录因子3像4 (BTF3L4) 在质瘤及其免疫细胞透中的作用尚不清楚.
研究的目的:
- 为了研究质瘤中的BTF3L4表达.
- 评估其预后价值和与免疫细胞透的相关性.
- 探索其在质瘤细胞行为中的功能作用.
主要方法:
- 对BTF3L4.4的基因表达概况和免疫组织化学.
- 使用考克斯回归和卡普兰-梅尔方法进行预测分析.
- 在体实验中对质瘤细胞系进行实验.
- 免疫细胞量化 (CIBERSORT,ESTIMATE) 和多重免疫组织化学.
主要成果:
- BTF3L4的表达在质瘤中高于非瘤组织,这与不良的临床特征和预后有关.
- 降低BTF3L4的调节会影响结质瘤细胞的增殖,迁移和侵入.
- 在质瘤中,BTF3L4与CD66B+中性粒细胞透和PD-L1表达相关.
结论:
- 在质瘤中,BTF3L4具有显著的预后价值.
- BTF3L4影响着质瘤细胞的攻击性.
- BTF3L4与特定的免疫透物有关,可能是质瘤免疫治疗的治疗点.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
General Transcription Factors
5.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Transcription Factors
75.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.8K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


